Dr. Alankar Shrivastava Achieves Outstanding Global Research Impact in Pharmaceutical Analysis and Quality Assurance

Raipur, Chhattisgarh: Dr. Alankar Shrivastava, Director and Principal of the Amity Institute of Pharmacy, Amity University Raipur, has emerged as one of India's highly influential pharmaceutical researchers, making exceptional contributions to pharmaceutical analysis, quality assurance, analytical method validation, drug delivery systems, and pharmaceutical sciences. His extensive body of work has earned widespread international recognition, positioning him among the leading researchers in analytical pharmaceutical sciences.

According to his Google Scholar profile, Dr. Shrivastava has achieved an impressive 5,180 citations, including 2,739 citations since 2021, reflecting the sustained global impact of his research. His scholarly profile records an h-index of 19 and an i10-index of 32, underscoring the significance and consistency of his scientific contributions over more than a decade.

One of his landmark publications, "Methods for the Determination of Limit of Detection and Limit of Quantitation of the Analytical Methods," published in Chronicles of Young Scientists (2011), has received more than 4,000 citations, making it one of the most extensively referenced articles in the field of pharmaceutical analytical method validation. The publication continues to serve as a standard reference for researchers, pharmaceutical industries, quality control laboratories, and regulatory scientists worldwide.

Dr. Shrivastava's research portfolio encompasses a broad range of pharmaceutical disciplines, including:

• Pharmaceutical Quality Assurance
• Analytical Method Development and Validation
• RP-HPLC and Spectrophotometric Analysis
• Pharmaceutical Formulation Development
• Drug Stability Studies
• Nanotechnology-Based Drug Delivery
• Herbal Medicines and Phytopharmaceuticals
• Pharmaceutical Regulatory Sciences
• Clinical Research
• Essential Oil Extraction Technologies

Over the years, he has published influential research on analytical methodologies for various pharmaceutical compounds, including tamsulosin hydrochloride, hydroxychloroquine, artemether, ramipril, telmisartan, prazosin, terazosin, doxazosin, and nebivolol, significantly contributing to advancements in pharmaceutical quality control and analytical chemistry.

His highly cited review articles on peppermint oil, benign prostatic hyperplasia, and analytical method validation continue to guide researchers, pharmaceutical professionals, and postgraduate students across the globe. More recent contributions explore emerging fields such as nanotechnology for combating viral infections, advanced drug delivery systems using native starch modifications, steam distillation techniques for medicinal plants, and analytical characterization of pharmaceutical excipients, reflecting his continued engagement with evolving pharmaceutical research.

Dr. Shrivastava has also collaborated extensively with national and international researchers, contributing to multidisciplinary investigations in pharmaceutical sciences, medicinal chemistry, herbal drug development, pharmaceutical biotechnology, and quality assurance. His publications have appeared in several internationally reputed journals, including BioMed Research International, Scientia Pharmaceutica, Journal of Midlife Health, Current Pharmaceutical Analysis, Journal of Young Pharmacists, International Journal of Applied Pharmaceutics, Chronicles of Young Scientists, and numerous other high-impact scientific journals.

As an academic leader, Dr. Shrivastava has played a pivotal role in strengthening pharmaceutical education, promoting quality research, and mentoring young researchers. Through his leadership at Amity Institute of Pharmacy, he continues to foster innovation, encourage interdisciplinary collaborations, and advance evidence-based pharmaceutical research aligned with global healthcare priorities.

Dr. Alankar Shrivastava's remarkable citation record, impactful scientific publications, and sustained contributions to pharmaceutical analysis and quality assurance exemplify academic excellence and reinforce India's growing prominence in global pharmaceutical research. His work continues to influence researchers, educators, pharmaceutical industries, and healthcare professionals worldwide, contributing meaningfully to the advancement of modern pharmaceutical sciences.